Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.
about
From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcoticsCannabinoid and opioid interactions: implications for opiate dependence and withdrawalCurrent research on opioid receptor function.Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics.Healthcare utilization of individuals with opiate use disorders: an analysis of integrated medicaid and state mental health/substance abuse agency dataPsychopharmacological effects of oxycodone in healthy volunteers: roles of alcohol-drinking status and sexA possible link between sensation-seeking status and positive subjective effects of oxycodone in healthy volunteers.Strategies to prevent opioid misuse, abuse, and diversion that may also reduce the associated costs.A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers.Costs of care for persons with opioid dependence in commercial integrated health systems.Prescription drug abuse: insight into the epidemic.Prescription Drug Abuse & Diversion: Role of the Pain Clinic.Prescription opioid abuse: a literature review of the clinical and economic burden in the United States.Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation.Employment-based abstinence reinforcement following inpatient detoxification in HIV-positive opioid and/or cocaine-dependent patients.Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control studyComparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial.Oxycodone abuse in New York City: characteristics of intravenous and intranasal users.Prescription use disorders in older adults.Nonmedical use of prescription opioids: motive and ubiquity issuesAdoption of medications in substance abuse treatment: priorities and strategies of single state authoritiesAssessment of a formulation designed to be crush-resistant in prescription opioid abusers.Prescription opioid abuse: challenges and opportunities for payers.Evaluation of ongoing oxycodone abuse among methadone-maintained patientsDoes opioid pain medication use affect the outcome of patients with lumbar disc herniation?Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients.Issues in long-term opioid therapy: unmet needs, risks, and solutions.Prescription patterns of benzodiazepines in the Lebanese adult population: a cross-sectional studyIncreasing pregnancy-related use of prescribed opioid analgesicsCost and comorbidities associated with opioid abuse in managed care and Medicaid patients in the United Stated: a comparison of two recently published studies.Lessons learned in the abuse of pain-relief medication: a focus on healthcare costs.The challenges of LC-MS/MS analysis of opiates and opioids in urine.The economic burden of diagnosed opioid abuse among commercially insured individuals.The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013.Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review.Pain Management of Patients with Substance Abuse in the Ambulatory Setting.Experience with an extended-release opioid formulation designed to reduce abuse liability in a community-based pain management clinic.Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic.Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs.The economic burden of opioid-related poisoning in the United States.
P2860
Q24648063-5D760B2E-B732-4BA2-8142-6A0BBA55EF21Q27000762-835C720D-4BA2-4F15-9FD1-043C153CDB3FQ27693220-7ADB5306-2EE5-46DB-973B-9273FA62E77CQ30677208-BE2712D8-FB5B-4BD3-81C0-09186B6C48F6Q31115026-69A6DC72-6F03-4232-A8E8-54B8F8722FF9Q33653525-BEDEC611-2589-4948-B853-B05625CB62CDQ33835583-520F870F-2750-431D-B884-9A4B9C182811Q33932344-F592AADA-AAB7-44DA-9630-9EB4E8826D35Q34040286-1FF913C2-7DDA-4B7A-B3D4-DEA0A7EE797CQ34079752-BED9B92E-EC57-40F6-A159-B98DAD162BBDQ34129781-813F01BF-734B-4508-85D3-16E23F40F68FQ34537419-56AF631E-9554-4992-B58B-A195CE68541EQ34751280-6C087BB1-C017-42A0-9E70-D00200C8C56CQ34808676-6BEE2FAC-F536-4ABC-8574-538857B2311AQ35095930-5B39AE53-3B2E-4A72-B55D-F973FF131B46Q35156524-311BE28E-4959-45BE-B3C7-802930E2C243Q35189633-4051073A-120D-416A-BD34-1BFD048E737FQ35873865-921685E0-365E-4402-BCB2-EAC0A042C06EQ35873868-875FECD1-FF6B-47EE-9BD4-FC73A5D93185Q36693189-8BC52170-C581-4725-879A-AF682D84DD68Q36806539-22142FC5-F4F5-4361-85FD-894638DC2685Q36845718-4B75AF62-02CB-49C9-A4D1-11F687549973Q36922546-FAB8E579-2269-4E03-8842-76EA997300E1Q36980798-826D58C2-45D1-4664-AE5F-A509CF727026Q37032220-356D7F12-8C39-455F-AD17-D405D7D0F636Q37105100-947F8EB2-DDE9-4CBD-853F-2131CBE09824Q37246241-C3686903-2819-429E-B07F-6800158FCA70Q37249127-DA564A72-C75D-4B84-A7B6-8412FF693C2BQ37464251-214A21AE-BB7D-4693-875E-4DB3078A509EQ37780763-BB5895D9-D7B2-422A-942B-5CB79627FF82Q38101985-1B188A6A-2857-4F28-A26D-0AB06648E3F4Q38164427-C0D1ADAB-10F6-429A-BBEF-6DEE87924F69Q38241634-4BCABA47-F7C4-45D2-A179-6C6E205DFCE5Q38405700-5ADAF7F5-8D27-4240-A7B8-C7029F48FD7DQ38665432-BE2935AF-5875-4667-9882-96ECBD465A61Q38751647-2EE03151-004A-4BAE-A86B-9DCE9964F846Q38905036-83326B7B-D8BD-4B14-85E6-61E84E871617Q38923769-D6285FB4-5ABC-48D2-9948-9021082E8982Q39002018-4E91CC6C-EE9C-4907-B484-522DA92020A2Q39387412-4B8FAB03-9C56-40E2-B861-CAA61DC49AF1
P2860
Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.
description
2006 nî lūn-bûn
@nan
2006 թվականի հոկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Estimated costs of prescriptio ...... 2001: a societal perspective.
@en
Estimated costs of prescriptio ...... 2001: a societal perspective.
@nl
type
label
Estimated costs of prescriptio ...... 2001: a societal perspective.
@en
Estimated costs of prescriptio ...... 2001: a societal perspective.
@nl
prefLabel
Estimated costs of prescriptio ...... 2001: a societal perspective.
@en
Estimated costs of prescriptio ...... 2001: a societal perspective.
@nl
P2093
P1476
Estimated costs of prescriptio ...... 2001: a societal perspective.
@en
P2093
Alan G White
Howard G Birnbaum
Jeff R Schein
Jennifer L Reynolds
Mingliang Zhang
Nathaniel P Katz
Paul E Greenberg
Sue Vallow
P304
P356
10.1097/01.AJP.0000210915.80417.CF
P407
P577
2006-10-01T00:00:00Z